Interestingly, in another study, elevated galectin-3 levels also predicted admission to intensive care, but this was not restricted to COVID-19, but patients with respiratory viral infection, bacterial pneumonia or non-infectious inflammatory diseases [80] were also included, indicating that serum galectin-3 levels have a much broader potential as a prognostic marker beyond COVID-19. The gene discussed is LGALS3; the disease is COVID-19.